End User Resources
A collection of materials developed by the Prevention Market Manager team and partners to support end-user work
Human-Centered Design in Global Health & Development: Guidance to Maximize Impact and Mitigate Risk
This AVAC report provides a thorough analysis of the greatest pain points and risk areas that donors, implementers and practitioners face throughout the human-centered design process in global health and development projects. Based on 45 interviews, this document provides a framework of essential steps, inputs and strategies for successful HCD programs.
The Landscape For End User Research: Mapping and Findings
The HIV Prevention Market Manager undertook an effort to map the landscape of ongoing and planned work on bringing HIV prevention to adolescent girls and young women and other populations in sub-Saharan Africa. This document provides a summary and analysis of the end-user projects and studies underway. This information can be used to inform collaborations and identify gaps and next steps in research.
Oral PrEP Mapping in Kenya and Zimbabwe
The HIV Prevention Market Manager has created maps for Kenya and Zimbabwe to highlight the range of actors working on oral PrEP in each country. Organizations and projects are mapped across area of focus (advocacy, guidelines, government, research, end user/marketing, implementation, technical assistance, coordination, monitoring and evaluation (M&E), regulation/registration, packaging, product modification, provider training, clinical monitoring, supply, communications, funding), by population focus and district/county. The mapping will be updated on an annual basis. For any updates or corrections to the information included please contact firstname.lastname@example.org.
Traditional Socio-Behavioral Research and Human-Centered Design: Similarities, unique contributions and synergies
This report by Dr. Betsy Tolley (FHI 360) presents learnings and reflections on traditional socio-behavioral research (SBR) and human-centered design (HCD) as applied to the global health context–specifically in biomedical prevention for sexual and reproductive health. In comparing these methodologies and examining their strengths and shortcomings, we can identify potential synergies to further inform the development and introduction of biomedical prevention in targeted end-user populations. Also check out Elizabeth Russell’s companion piece on the USAID Office of HIV/AIDS Research Blog.